WILLIAM R. SALYER, M.D.; DIANE C. SALYER, M.D.; ROBERT H. HEPTINSTALL, M.D.
Microangiopathic hemolytic anemia was found in 7 of 20 patients with systemic scleroderma, an indication that this complication is not uncommon. Since only four had severe hypertension, pressures in the "malignant" range seem not to be necessary for the development of the anemia. All seven patients had renal arterial fibrin deposits, which supports the concept that erythrocyte fragmentation results from contact with intravascular fibrin.
Learn more about subscription options.
Register Now for a free account.
SALYER WR, SALYER DC, HEPTINSTALL RH. Scleroderma and Microangiopathic Hemolytic Anemia. Ann Intern Med. 1973;78:895–897. doi: 10.7326/0003-4819-78-6-895
Download citation file:
Published: Ann Intern Med. 1973;78(6):895-897.
Hematology/Oncology, Red Cell Disorders, Rheumatology, Scleroderma.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only